申请人:Hoffmann-La Roche Inc.
公开号:US11390610B2
公开(公告)日:2022-07-19
The invention provides new heterocyclic compounds having the general Formula (I), or a pharmaceutically acceptable salt thereof,
wherein R1, R2, X, Y1 and Y2 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
本发明提供了具有通式(I)的新杂环化合物或其药学上可接受的盐、
其中 R1、R2、X、Y1 和 Y2 如本文所述。